Sivan Kagan, PhD, is an accomplished scientist specializing in immunology and biopharma research. Sivan's experience includes serving as a Global R&D Project Manager at Merck Group, where leadership of two global bifunctional antibody projects in immune oncology involved project proposal, antibody design, optimization, and preclinical studies. As an R&D Senior Scientist at Merck Biopharma, Sivan contributed to the Immuno-Oncology team. Currently, Sivan is the Head of Development at Enlivex Therapeutics, overseeing the process development of a cell-based product while managing a team of scientists. Sivan's academic background includes a PhD in Molecular Biology and a Master's degree from the Weizmann Institute of Science, with a research focus on dendritic cells and their role in cancer immunology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices